JPY 2388.0
(0.55%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 39.79 Billion JPY | 8.09% |
2022 | 36.81 Billion JPY | 5.79% |
2021 | 34.8 Billion JPY | -3.84% |
2020 | 36.19 Billion JPY | -1.79% |
2019 | 36.85 Billion JPY | -5.13% |
2018 | 38.84 Billion JPY | 3.29% |
2017 | 37.6 Billion JPY | 3.77% |
2016 | 36.24 Billion JPY | -0.54% |
2015 | 36.44 Billion JPY | 3.85% |
2014 | 35.08 Billion JPY | 3.96% |
2013 | 33.75 Billion JPY | -12.9% |
2012 | 38.75 Billion JPY | 10.94% |
2011 | 34.93 Billion JPY | 5.24% |
2010 | 33.19 Billion JPY | -12.05% |
2009 | 37.73 Billion JPY | -1.0% |
2008 | 38.11 Billion JPY | 1.69% |
2007 | 37.48 Billion JPY | -3.02% |
2006 | 38.65 Billion JPY | 0.61% |
2005 | 38.42 Billion JPY | 4.62% |
2004 | 36.72 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 39.64 Billion JPY | -0.36% |
2023 Q4 | 39.79 Billion JPY | -4.41% |
2023 Q3 | 41.62 Billion JPY | 3.04% |
2023 FY | 39.79 Billion JPY | 8.09% |
2023 Q2 | 40.39 Billion JPY | 4.27% |
2023 Q1 | 38.74 Billion JPY | 5.24% |
2022 Q1 | 36.72 Billion JPY | 5.51% |
2022 Q4 | 36.81 Billion JPY | -1.63% |
2022 FY | 36.81 Billion JPY | 5.79% |
2022 Q3 | 37.42 Billion JPY | 3.53% |
2022 Q2 | 36.15 Billion JPY | -1.55% |
2021 Q3 | 36.36 Billion JPY | 0.39% |
2021 Q1 | 35.93 Billion JPY | -0.71% |
2021 Q2 | 36.22 Billion JPY | 0.81% |
2021 Q4 | 34.8 Billion JPY | -4.3% |
2021 FY | 34.8 Billion JPY | -3.84% |
2020 Q1 | 36.88 Billion JPY | 0.08% |
2020 Q4 | 36.19 Billion JPY | -6.3% |
2020 FY | 36.19 Billion JPY | -1.79% |
2020 Q3 | 38.62 Billion JPY | 2.77% |
2020 Q2 | 37.58 Billion JPY | 1.9% |
2019 Q4 | 36.85 Billion JPY | -5.38% |
2019 FY | 36.85 Billion JPY | -5.13% |
2019 Q1 | 38.47 Billion JPY | -0.95% |
2019 Q3 | 38.94 Billion JPY | 4.28% |
2019 Q2 | 37.35 Billion JPY | -2.93% |
2018 FY | 38.84 Billion JPY | 3.29% |
2018 Q1 | 38.97 Billion JPY | 3.63% |
2018 Q2 | 40.08 Billion JPY | 2.86% |
2018 Q3 | 40.16 Billion JPY | 0.19% |
2018 Q4 | 38.84 Billion JPY | -3.29% |
2017 FY | 37.6 Billion JPY | 3.77% |
2017 Q4 | 37.6 Billion JPY | -1.88% |
2017 Q3 | 38.32 Billion JPY | -1.4% |
2017 Q2 | 38.87 Billion JPY | 4.97% |
2017 Q1 | 37.03 Billion JPY | 2.18% |
2016 Q3 | 38.62 Billion JPY | 2.3% |
2016 Q1 | 38.31 Billion JPY | 5.15% |
2016 Q2 | 37.75 Billion JPY | -1.46% |
2016 FY | 36.24 Billion JPY | -0.54% |
2016 Q4 | 36.24 Billion JPY | -6.17% |
2015 Q2 | 38.92 Billion JPY | 10.48% |
2015 Q3 | 39.61 Billion JPY | 1.79% |
2015 Q4 | 36.44 Billion JPY | -8.02% |
2015 Q1 | 35.22 Billion JPY | 0.4% |
2015 FY | 36.44 Billion JPY | 3.85% |
2014 Q2 | 36.27 Billion JPY | 2.91% |
2014 Q3 | 36.48 Billion JPY | 0.59% |
2014 FY | 35.08 Billion JPY | 3.96% |
2014 Q1 | 35.24 Billion JPY | 4.43% |
2014 Q4 | 35.08 Billion JPY | -3.84% |
2013 FY | 33.75 Billion JPY | -12.9% |
2013 Q4 | 33.75 Billion JPY | -5.3% |
2013 Q1 | 35.87 Billion JPY | -7.43% |
2013 Q2 | 35.86 Billion JPY | -0.02% |
2013 Q3 | 35.64 Billion JPY | -0.63% |
2012 Q3 | 40.38 Billion JPY | 7.47% |
2012 Q4 | 38.75 Billion JPY | -4.03% |
2012 Q2 | 37.57 Billion JPY | 2.12% |
2012 Q1 | 36.79 Billion JPY | 5.34% |
2012 FY | 38.75 Billion JPY | 10.94% |
2011 Q3 | 37.12 Billion JPY | 0.81% |
2011 FY | 34.93 Billion JPY | 5.24% |
2011 Q1 | 33.62 Billion JPY | 1.3% |
2011 Q2 | 36.82 Billion JPY | 9.54% |
2011 Q4 | 34.93 Billion JPY | -5.92% |
2010 Q3 | 36.73 Billion JPY | -3.15% |
2010 Q1 | 38.24 Billion JPY | 1.33% |
2010 FY | 33.19 Billion JPY | -12.05% |
2010 Q4 | 33.19 Billion JPY | -9.66% |
2010 Q2 | 37.93 Billion JPY | -0.81% |
2009 Q3 | 40.04 Billion JPY | 1.28% |
2009 Q4 | 37.73 Billion JPY | -5.77% |
2009 Q2 | 39.54 Billion JPY | 0.0% |
2009 FY | 37.73 Billion JPY | -1.0% |
2008 Q4 | 38.11 Billion JPY | -3.98% |
2008 FY | 38.11 Billion JPY | 1.69% |
2008 Q3 | 39.69 Billion JPY | 0.0% |
2007 FY | 37.48 Billion JPY | -3.02% |
2006 FY | 38.65 Billion JPY | 0.61% |
2005 FY | 38.42 Billion JPY | 4.62% |
2004 FY | 36.72 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -59.252% |
Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.492% |
Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 94.704% |
Shionogi & Co., Ltd. | 164.35 Billion JPY | 75.788% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1072.143% |
Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 7.171% |
Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -42.805% |
Eisai Co., Ltd. | 494.82 Billion JPY | 91.958% |
Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -689.563% |
Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 35.498% |
Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -29.067% |
Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -28.021% |
Tsumura & Co. | 132.88 Billion JPY | 70.054% |
Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -0.008% |
Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -199.271% |
Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 85.517% |
Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 9.883% |
Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 43.718% |
KYORIN Holdings, Inc. | 46.89 Billion JPY | 15.139% |
Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -468.242% |
Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -56.429% |
SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -388.742% |
MedRx Co., Ltd | 129 Million JPY | -30748.062% |
Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -1115.999% |
Solasia Pharma K.K. | 673 Million JPY | -5812.927% |
Modalis Therapeutics Corporation | 645.5 Million JPY | -6064.805% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -26.809% |
Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 75.734% |
Cyfuse Biomedical K.K. | 1.01 Billion JPY | -3834.78% |
Toho Holdings Co., Ltd. | 523.98 Billion JPY | 92.406% |
Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -472.383% |